RED HOT Contributors


STAT Plus: Democrats urge Trump to issue guidelines for overriding patents on pricey drugs



ore than 50 Democratic lawmakers have told President Trump that he can take one step himself to lower drug prices:  Instruct the National Institutes of Health to override patents for medicines that were discovered with federal funds, but carry price tags that are out of reach for many Americans.

In a letter sent on Tuesday, they argued the NIH should be encouraged to pursue so-called march-in rights. Under a 1980 federal law, this allows an agency that funds private research to require a drug maker to license its patent to another party in order to “alleviate health and safety needs which are not being reasonably satisfied” or when the benefits of a drug are not available on “reasonable terms.”

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.


We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast